Your browser doesn't support javascript.
loading
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.
Radocha, Jakub; Jelinek, Tomas; Pour, Ludek; Spicka, Ivan; Minarik, Jiri; Popkova, Tereza; Jungova, Alexandra; Pavlicek, Petr; Brozova, Lucie; Stork, Martin; Sedlak, Frantisek; Krhovska, Petra; Maisnar, Vladimir; Heindorfer, Adriana; Sykora, Michal; Wrobel, Marek; Mikula, Peter; Kessler, Petr; Ullrychova, Jana; Hajek, Roman.
Affiliation
  • Radocha J; Faculty of Medicine in Hradec Králové, 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
  • Jelinek T; Czech Myeloma Group, Brno, Czech Republic.
  • Pour L; Czech Myeloma Group, Brno, Czech Republic.
  • Spicka I; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Minarik J; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Popkova T; Czech Myeloma Group, Brno, Czech Republic.
  • Jungova A; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Usti nad Labem, Czech Republic.
  • Pavlicek P; Czech Myeloma Group, Brno, Czech Republic.
  • Brozova L; 1st Medical Department - Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.
  • Stork M; Czech Myeloma Group, Brno, Czech Republic.
  • Sedlak F; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
  • Krhovska P; Czech Myeloma Group, Brno, Czech Republic.
  • Maisnar V; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Heindorfer A; Czech Myeloma Group, Brno, Czech Republic.
  • Sykora M; Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic.
  • Wrobel M; Czech Myeloma Group, Brno, Czech Republic.
  • Mikula P; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Kessler P; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Ullrychova J; Czech Myeloma Group, Brno, Czech Republic.
  • Hajek R; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Usti nad Labem, Czech Republic.
Int J Lab Hematol ; 43(5): e244-e247, 2021 10.
Article in En | MEDLINE | ID: mdl-33452712
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Observational_studies Limits: Humans Language: En Journal: Int J Lab Hematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: República Checa Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Observational_studies Limits: Humans Language: En Journal: Int J Lab Hematol Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: República Checa Country of publication: Reino Unido